000 | 01819 a2200457 4500 | ||
---|---|---|---|
005 | 20250515112732.0 | ||
264 | 0 | _c20081218 | |
008 | 200812s 0 0 eng d | ||
022 | _a1461-1457 | ||
024 | 7 |
_a10.1017/S146114570800847X _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aFlaisher-Grinberg, Shlomit | |
245 | 0 | 0 |
_aThe role of 5-HT2A and 5-HT2C receptors in the signal attenuation rat model of obsessive-compulsive disorder. _h[electronic resource] |
260 |
_bThe international journal of neuropsychopharmacology _cSep 2008 |
||
300 |
_a811-25 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAmphetamines _xadministration & dosage |
650 | 0 | 4 | _aAnalysis of Variance |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBehavior, Animal _xdrug effects |
650 | 0 | 4 |
_aCompulsive Behavior _xdrug therapy |
650 | 0 | 4 |
_aConditioning, Operant _xdrug effects |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aDrug Combinations |
650 | 0 | 4 |
_aExtinction, Psychological _xdrug effects |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aObsessive-Compulsive Disorder _xdrug therapy |
650 | 0 | 4 |
_aPiperidines _xadministration & dosage |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 |
_aReceptor, Serotonin, 5-HT2A _xphysiology |
650 | 0 | 4 |
_aReceptor, Serotonin, 5-HT2C _xphysiology |
650 | 0 | 4 | _aSerotonin 5-HT2 Receptor Antagonists |
650 | 0 | 4 |
_aSpiro Compounds _xadministration & dosage |
650 | 0 | 4 |
_aSulfonamides _xadministration & dosage |
700 | 1 | _aKlavir, Oded | |
700 | 1 | _aJoel, Daphna | |
773 | 0 |
_tThe international journal of neuropsychopharmacology _gvol. 11 _gno. 6 _gp. 811-25 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1017/S146114570800847X _zAvailable from publisher's website |
999 |
_c17840941 _d17840941 |